In somatic cells, the Raf-I serine/threonine protein kinase is activated by several polypeptide growth factors. We investigated the role of Raf-I in progesterone-induced meiotic maturation ofXenopus laevis oocytes. Raf-l enzymatic activity and phosphorylation (reflected by a mobility shift on sodium dodecyl sulfate gels) were increased in oocytes following progesterone stimulation. The increase in Raf-I activity was concurrent with an elevation in the activity of mitogen-activated protein (MAP) kinase. When RNA encoding an oncogenic form of Raf-1 (v-Raf) was injected into immature oocytes, MAP kinase mobility shift, germinal vesicle breakdown, and histone Hi phosphorylation increased markedly. When RNA encoding a dominant-negative version of Raf-I was injected, progesterone-induced oocyte maturation was blocked. When RNA encoding Xenopus mos (mosxe) was injected into oocytes, Raf-1 and MAP kinase mobility shifts were observed after several hours. Also, when antisense mosxe oligonucleotides were injected into oocytes, progesterone-induced Raf-1 and MAP kinase mobility shifts were blocked. Finally, when antisense mosxe oligonucleotides were coinjected with v-Raf RNA into oocytes, histone Hi kinase activation, germinal vesicle breakdown, and MAP kinase mobility shift occurred. These findings suggest that Raf-I activity is required for progesterone-induced oocyte maturation and that Raf-1 is downstream of mos' activity.The Raf-1 serine/threonine protein kinase is activated in cultured cells by a variety of growth factors (18,19,21). Raf-1 activity is necessary for somatic cell transformation by a variety of oncogenes and is also necessary for growth factor-induced proliferation of certain cultured cells (9). Raf-1 consists of an amino-terminal regulatory domain and a carboxyl-terminal kinase domain. An oncogenic form of Raf-1, v-Raf, has an amino-terminal deletion of much of the putative regulatory domain (22,26).When wild-type Raf-1 is activated, it has the ability to phosphorylate and activate mitogen-activated protein (MAP) kinase kinase in vitro and in cultured cells (2,6,12 made by performing M13 site-directed mutagenesis, converting lysine 375 to methionine (K375M) as described previously (15). The NAF and wild-type Raf-1 cDNAs were inserted into the pSP64T vector, and the constructs were modified by insertion of an oligonucleotide encoding the KT3 peptide at the 3' ends of the coding regions.The full-length mosxe cDNA construct and the mosxe antisense oligonucleotides were generous gifts of Daniel J. Donoghue (University of California, San Diego) (4, 5, 7).RNA containing a 5'-GpppG cap (Pharmacia LKB Biotechnology Inc.) was made by using linearized plasmid with the SP6 RNA polymerase (Boehringer Mannheim) as described previously (17) and resuspended in water.Oocyte inijections. Large oocytes (Dumont stage VI) were removed from adult female frogs by using established techniques. Oocytes were manually dissected and collagenase treated (Sigma type II, 1 mg/ml). Oocytes were maintained in lx modified Barth's sali...